Table 2.
Comparison of antibiotics sensitivity pattern of A. baumannii isolated from 2019–2020.
| S. No. | Antibiotics | 2019—Total A. baumannii = 35 n (%) |
2020—Total A. baumannii = 47 n (%) |
|---|---|---|---|
| 1 | Colistin (10 µg) | 35 (100) | 43 (91.4) |
| 2 | Amikacin (30 µg) | 4 (11.4) | 22 (48.9) |
| 3 | Piperacillin-Tazobactam (100 µg/10 µg) | R | 1 (2.1) |
| 4 | Piperacillin (100 µg) | 1 (2.8) | R |
| 5 | Gentamicin (10 µg) | 4 (11.4) | 8 (17) |
| 6 | Meropenem (10 µg) | R | 1 (2.1) |
| 7 | Imipenem (10 µg) | R | 1 (2.1) |
| 8 | Ciprofloxacin (5 µg) | R | R |
| 9 | Teicoplanin (30 µg) | 1 (2.8) | 9 (19.1) |
| 10 | Aztreonam (30 µg) | R | R |
| 11 | Cefepime (30 µg) | R | 5 (10.6) |
| 12 | Ceftazidime (30 µg) | 1 (2.8) | R |
| 13 | Amoxicillin/clavulanic acid (20/10 µg) | R | R |
| 14 | Trimethoprim/Sulfamethoxazole (1.25/23.75 µg) | 2 (5.7) | R |
| 15 | Cefoxitin (30 µg) | R | R |
| 16 | Ertapenem (10 µg) | R | R |
| 17 | Cefuroxime (30 µg) | R | R |
| 18 | Ampicillin (10 µg) | R | R |
| 19 | Tigecycline (15 µg) | 1 (2.8) | 7 (14.8) |
| 20 | Levofloxacin (5 µg) | R | 1 (2.1) |
| 21 | Ceftriaxone (30 µg) | R | R |